mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.02 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.02 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |